West Family Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Buy
+3,528
New +$206K 0.08% 236
2025
Q4
Sell
-6,797
Closed -$307K 359
2025
Q3
$307K Sell
6,797
-4,060
-37% -$190K 0.07% 281
2025
Q2
$503K Buy
10,857
+4,766
+78% +$234K 0.13% 161
2025
Q1
$371K Sell
6,091
-620
-9% -$36.1K 0.14% 145
2024
Q4
$380K Buy
6,711
+992
+17% +$55.4K 0.13% 159
2024
Q3
$296K Buy
+5,719
New +$268K 0.1% 208
2024
Q2
Sell
-4,511
Closed -$245K 255
2024
Q1
$245K Sell
4,511
-1,585
-26% -$80.7K 0.08% 215
2023
Q4
$313K Buy
6,096
+2,381
+64% +$125K 0.11% 147
2023
Q3
$216K Sell
3,715
-8,457
-69% -$518K 0.08% 199
2023
Q2
$778K Buy
+12,172
New +$816K 0.3% 73
2023
Q1
Sell
-12,254
Closed -$882K 217
2022
Q4
$882K Buy
12,254
+1,774
+17% +$134K 0.3% 67
2022
Q3
$745K Buy
10,480
+598
+6% +$43.4K 0.31% 70
2022
Q2
$761K Buy
9,882
+4,028
+69% +$307K 0.3% 66
2022
Q1
$428K Buy
5,854
+1,013
+21% +$68K 0.12% 139
2021
Q4
$302K Sell
4,841
-2,720
-36% -$160K 0.08% 203
2021
Q3
$447K Buy
7,561
+437
+6% +$28.8K 0.12% 154
2021
Q2
$476K Buy
+7,124
New +$465K 0.13% 137

Other funds holding BMY

West Family Investments's BMY Position: Q1 2026 in Review

West Family Investments opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 3,528 shares worth $214K. The stake represents 0.08% of the portfolio and ranks #236 among its holdings. This is a return to the name: West Family Investments previously reported a position in BMY as recently as Q3 2025.

West Family Investments first reported a position in BMY in Q2 2021 and has held it in 17 quarters since. The position peaked at $882K in Q4 2022. 2,522 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • West Family Investments held 3,528 shares of Bristol-Myers Squibb worth $214K as of Q1 2026.
  • Bristol-Myers Squibb was a new West Family Investments position in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of West Family Investments's portfolio in Q1 2026, its #236 holding.
  • West Family Investments first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 17 quarters since.
  • West Family Investments's Bristol-Myers Squibb position peaked at $882K in Q4 2022.
  • 2,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.